Interestingly, the mitotic rate of tumor cells quantified by PH3 immunolabeling was strictly similar in control and OLFM1 Ab-treated groups, showing that NB cell proliferation was unaffected by OLFM1 Ab treatment (Fig. 5d, e). Here, PHC3 is linked to neoplasm.